Novo Integrated Sciences Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Novo Integrated Sciences Inc 的收入按细分市场或地理位置如何划分?
Novo Integrated Sciences Inc 最大收入来源是 Healthcare Services,在最近的收益报告中收入为 8,297,530。就地区而言, United States 是 Novo Integrated Sciences Inc 的主要市场,收入为 13,294,357。
Novo Integrated Sciences Inc 是否盈利?
否,根据最新的财务报表,Novo Integrated Sciences Inc 的净亏损为 $0
Novo Integrated Sciences Inc 有负债吗?
否,Novo Integrated Sciences Inc 的负债为 0
Novo Integrated Sciences Inc 的流通股有多少?
Novo Integrated Sciences Inc 的总流通股为 0
关键数据
前收盘价
$0.0022
开盘价
$0.0035
当日区间
$0.0022 - $0.005
52周范围
$0.0001 - $0.06
交易量
1.5K
平均成交量
6.2K
股息收益率
--
每股收益(TTM)
-0.91
市值
$44.3K
什么是 NVOS?
Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.